Watch CC. Know when insiders buy.
One email the day a filing lands. Free.
CC
Chemours Co
15.04
−0.41 −2.65%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
36
FLAG · shorts 36
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.3BP/E —DIV YIELD 2.33%FCF YIELD 9.63%REV TTM $5.8B −0.9%NET INCOME −$304MNET DEBT $2.9B52W 10.48 – 27.94SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.6B | −1.5% | 18.0% | — | −$274M | — | -1.81 | $158M | $44M | $114M | Aug 5 |
| Q1 2026 · Mar 31 | $1.4B | +1.0% | 15.4% | — | −$29M | — | -0.19 | −$44M | $49M | −$93M | May 5 |
| Q4 2025 · Dec 31 | $1.3B | −2.2% | 11.7% | — | −$47M | — | -0.31 | $137M | $45M | $92M | Feb 24 |
| Q3 2025 · Sep 30 | $1.5B | −0.9% | 15.6% | — | $46M | — | 0.31 | $146M | $41M | $105M | Feb 24 |
| Q2 2025 · Jun 30 | $1.6B | +3.9% | 17.2% | — | −$380M | −733.3% | -2.53 | $93M | $43M | $50M | Aug 5 |
| Q1 2025 · Mar 31 | $1.4B | +0.4% | 17.3% | — | −$5M | −109.3% | -0.03 | −$112M | $84M | −$196M | May 5 |
| Q4 2024 · Dec 31 | $1.4B | −0.7% | 19.5% | — | −$11M | — | -0.08 | $138M | $109M | $29M | Feb 24 |
| Q3 2024 · Sep 30 | $1.5B | +0.5% | 19.0% | — | −$32M | −366.7% | -0.22 | $139M | $76M | $63M | Feb 24 |
| Q2 2024 · Jun 30 | $1.6B | — | 19.8% | — | $60M | — | 0.39 | −$620M | $73M | −$693M | Feb 24 |
| Q1 2024 · Mar 31 | $1.4B | — | 20.9% | — | $54M | — | 0.36 | −$290M | $102M | −$392M | Feb 24 |
| Q4 2023 · Dec 31 | $1.4B | — | 18.3% | — | −$18M | — | -0.12 | $482M | $135M | $347M | Feb 24 |
| Q3 2023 · Sep 30 | $1.5B | — | 18.2% | — | $12M | — | 0.08 | $131M | $86M | $45M | Feb 18 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $5.8B | 15.5% | — | −$386M | -6.6% | -2.57 | $264M | $213M | $51M | — | $78M |
| FY2024 · to Dec 31 | $5.8B | 19.8% | — | $69M | 1.2% | 0.46 | −$633M | $360M | −$993M | — | $148M |
| FY2023 · to Dec 31 | $6.1B | 21.4% | — | −$253M | -4.2% | -1.70 | $556M | $370M | $186M | $69M | $149M |
| FY2022 · to Dec 31 | $6.8B | 23.7% | — | $578M | 8.5% | 3.65 | $755M | $307M | $448M | $495M | $154M |
| FY2021 · to Dec 31 | $6.3B | 21.8% | — | $608M | 9.6% | 3.60 | $814M | $277M | $537M | $173M | $164M |
| FY2020 · to Dec 31 | $5B | 21.5% | — | $219M | 4.4% | 1.32 | $807M | $267M | $540M | $0 | $164M |
Every number comes from Chemours Co's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.